Ischemia Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, H1, 2012' provides data on the Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Reasons to buy
Keywords
Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Ischemia , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Summary
GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, H1, 2012' provides data on the Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Ischemia , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Introduction
Ischemia
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Ischemia
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Ischemia Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Sanofi
Clinical Trial Overview of Sanofi
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
TCA Cellular Therapy, LLC
Clinical Trial Overview of TCA Cellular Therapy, LLC
ViroMed Co., Ltd.
Clinical Trial Overview of ViroMed Co., Ltd.
Sangart, Inc.
Clinical Trial Overview of Sangart, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
AnGes MG, Inc.
Clinical Trial Overview of AnGes MG, Inc.
Pluristem Therapeutics Inc.
Clinical Trial Overview of Pluristem Therapeutics Inc.
Medistem, Inc.
Clinical Trial Overview of Medistem, Inc.
Stempeutics Research Private Limited
Clinical Trial Overview of Stempeutics Research Private Limited
St Vincent's Hospital Melbourne Pty Ltd
Clinical Trial Overview of St Vincent's Hospital Melbourne Pty Ltd
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Aastrom Biosciences, Inc.
Clinical Trial Overview of Aastrom Biosciences, Inc.
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
medac GmbH
Clinical Trial Overview of medac GmbH
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Lantheus Medical Imaging, Inc.
Clinical Trial Overview of Lantheus Medical Imaging, Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Scios Inc.
Clinical Trial Overview of Scios Inc.
Medicure Inc.
Clinical Trial Overview of Medicure Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Radboud University
Clinical Trial Overview of Radboud University
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
The University of Edinburgh
Clinical Trial Overview of The University of Edinburgh
Northwestern University
Clinical Trial Overview of Northwestern University
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
University Hospital Freiburg
Clinical Trial Overview of University Hospital Freiburg
Rigshospitalet
Clinical Trial Overview of Rigshospitalet
Kyoto University
Clinical Trial Overview of Kyoto University
Xijing Hospital
Clinical Trial Overview of Xijing Hospital
Charite- Universitatsmedizin Berlin
Clinical Trial Overview of Charite- Universitatsmedizin Berlin
Kyushu University
Clinical Trial Overview of Kyushu University
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
Clinical Trial Overview of
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Maastricht University Medical Center
Clinical Trial Overview of Maastricht University Medical Center
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of Florida
Clinical Trial Overview of University of Florida
Laval University
Clinical Trial Overview of Laval University
Leiden University Medical Center
Clinical Trial Overview of Leiden University Medical Center
UMC Utrecht
Clinical Trial Overview of UMC Utrecht
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, BRIC Countries, 2012*
Ischemia Therapeutics Clinical Trials, G7 Countries, 2012*
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Clinical Trials, E7 Countries, 2012*
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Ischemia Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Ischemia Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular Therapy, LLC, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by St Vincent's Hospital Melbourne Pty Ltd, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lantheus Medical Imaging, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Scios Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laval University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012*
LIST OF FIGURES
Ischemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, G7 Countries (%), 2012*
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Clinical Trials, E7 Countries (%), 2012*
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Ischemia
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Ischemia
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Ischemia Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Sanofi
Clinical Trial Overview of Sanofi
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
TCA Cellular Therapy, LLC
Clinical Trial Overview of TCA Cellular Therapy, LLC
ViroMed Co., Ltd.
Clinical Trial Overview of ViroMed Co., Ltd.
Sangart, Inc.
Clinical Trial Overview of Sangart, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
AnGes MG, Inc.
Clinical Trial Overview of AnGes MG, Inc.
Pluristem Therapeutics Inc.
Clinical Trial Overview of Pluristem Therapeutics Inc.
Medistem, Inc.
Clinical Trial Overview of Medistem, Inc.
Stempeutics Research Private Limited
Clinical Trial Overview of Stempeutics Research Private Limited
St Vincent's Hospital Melbourne Pty Ltd
Clinical Trial Overview of St Vincent's Hospital Melbourne Pty Ltd
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Aastrom Biosciences, Inc.
Clinical Trial Overview of Aastrom Biosciences, Inc.
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
medac GmbH
Clinical Trial Overview of medac GmbH
Gilead Sciences, Inc.
Clinical Trial Overview of Gilead Sciences, Inc.
Lantheus Medical Imaging, Inc.
Clinical Trial Overview of Lantheus Medical Imaging, Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Scios Inc.
Clinical Trial Overview of Scios Inc.
Medicure Inc.
Clinical Trial Overview of Medicure Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Radboud University
Clinical Trial Overview of Radboud University
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
The University of Edinburgh
Clinical Trial Overview of The University of Edinburgh
Northwestern University
Clinical Trial Overview of Northwestern University
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
University Hospital Freiburg
Clinical Trial Overview of University Hospital Freiburg
Rigshospitalet
Clinical Trial Overview of Rigshospitalet
Kyoto University
Clinical Trial Overview of Kyoto University
Xijing Hospital
Clinical Trial Overview of Xijing Hospital
Charite- Universitatsmedizin Berlin
Clinical Trial Overview of Charite- Universitatsmedizin Berlin
Kyushu University
Clinical Trial Overview of Kyushu University
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
Clinical Trial Overview of
Johann Wolfgang Goethe University Hospitals
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
Maastricht University Medical Center
Clinical Trial Overview of Maastricht University Medical Center
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of Florida
Clinical Trial Overview of University of Florida
Laval University
Clinical Trial Overview of Laval University
Leiden University Medical Center
Clinical Trial Overview of Leiden University Medical Center
UMC Utrecht
Clinical Trial Overview of UMC Utrecht
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, BRIC Countries, 2012*
Ischemia Therapeutics Clinical Trials, G7 Countries, 2012*
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Clinical Trials, E7 Countries, 2012*
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Ischemia Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Ischemia Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular Therapy, LLC, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by St Vincent's Hospital Melbourne Pty Ltd, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lantheus Medical Imaging, Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Scios Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laval University, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012*
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012*
LIST OF FIGURES
Ischemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Ischemia Therapeutics Clinical Trials, G7 Countries (%), 2012*
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Clinical Trials, E7 Countries (%), 2012*
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology